Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AEROSPORIN STERILE POWDER 500000 UNIT — DIN 00004421

POLYMYXIN B SULFATE : 500000 UNIT · GLAXO WELLCOME INC. · POWDER FOR SOLUTION · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is AEROSPORIN STERILE POWDER?

AEROSPORIN STERILE POWDER 500000 UNIT contains POLYMYXIN B SULFATE : 500000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00004421, held by GLAXO WELLCOME INC., supplied as POWDER FOR SOLUTION for INTRATHECAL ; INTRAVENOUS ; INTRAMUSCULAR ; INHALATION ; TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-1998. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

Is there a generic Polymyxin B in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

2 holders have a Canadian DIN containing Polymyxin B, across 2 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
GLAXO WELLCOME INC.10AEROSPORIN STERILE POWDERNo marketed DIN
STERIMAX INC10POLYMYXIN B FOR INJECTION USPNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label500000 UNIT
Dosage formPOWDER FOR SOLUTION
RouteINTRATHECAL ; INTRAVENOUS ; INTRAMUSCULAR ; INHALATION ; TOPICAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substancePolymyxin B
ATC codeJ01XB02
AHFS class56:22.08 ; 04:04.16
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00004421
DIN (unpadded, as printed on some documents)4421
Brand nameAEROSPORIN STERILE POWDER
Generic / active ingredientPOLYMYXIN B SULFATE : 500000 UNIT
Market authorization holderGLAXO WELLCOME INC.
Health Canada schedulePrescription
ATC codeJ01XB02
ATC anatomical main groupJ — Anti-infectives for systemic use
ATC therapeutic subgroupJ01XB
Current statusCANCELLED POST MARKET
Status date30-Jul-1998
Original market date1988-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
POLYMYXIN B FOR INJECTION USP50 MGPOWDER FOR SOLUTIONSTERIMAX INCDORMANT02375893

2 · Same class — other molecules in ATC J01XB

MoleculeCanadian brandsDINsMarketedSourceable
ColistinCOLISTIMETHATE FOR INJECTION U.S.P. · COLISTIMETHATE FOR INJECTION USP · COLISTIMETHATE FOR INJECTION, USP · COLY-MYCIN M44Yes
Polymyxin BAEROSPORIN STERILE POWDER · POLYMYXIN B FOR INJECTION USP20Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC J01X

ATC subgroupMoleculesDINsMarketed
J01XADalbavancin · Telavancin · Vancomycin6223
J01XXBacitracin · Daptomycin · Fosfomycin · Lefamulin · Linezolid · +4 more5215
J01XENitrofurantoin249
J01XDMetronidazole72
J01XCFusidic Acid30

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00004421. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.